John Leaman

John Leaman is a highly accomplished professional with a diverse educational background and impressive experience in the healthcare and biotechnology industries.

He received his Master of Business Administration in Management, Healthcare from The Wharton School, showcasing his expertise in business leadership and healthcare management.

John also holds a Doctor of Medicine degree from the University of Pennsylvania School of Medicine, highlighting his strong medical background and understanding of the healthcare sector.

His educational journey includes a Bachelor of Arts in Psychology, Physiology, Philosophy from the University of Oxford, and a Bachelor of Science in Biology from Elizabethtown College, illustrating his multidisciplinary academic pursuits.

In terms of his professional experience, John Leaman has held significant roles in various organizations. He currently serves as the Chief Financial Officer at Impel Neuropharma, where he undoubtedly contributes his financial acumen and strategic insights to drive the company's success.

Prior to his current position, John was the Chief Financial Officer and Head of Corporate Strategy at Selecta Biosciences, showcasing his leadership and strategic planning skills in the biotechnology field.

His previous roles include Head of Corporate Development at Infacare Pharmaceuticals, Chief Financial Officer at Medgenics, Vice President of Commercial Assessment at Shire, General Partner at Devon Park Bioventures, and Associate Principal at Mckinsey & Company, demonstrating his extensive experience in financial management, corporate strategy, business development, commercial assessment, and consulting.

John Leaman's comprehensive educational background and rich professional experience make him a valuable asset in the healthcare and biotechnology sectors, where his expertise in finance, strategy, and management is highly regarded.